| | | | Index Performance | | Index | Sensex | Nifty | | Open | 18,496.03 | 5,315.55 | | High | 18,895.34 | 5,545.20 | | Low | 18,439.33 | 5,315.55 | | Today's Cls | 18,660.32 | 5,463.50 | | Prev Cls | 18,242.58 | 5,317.25 | | Change | 417.74 | 146.25 | | % Change | 2.29 | 2.75 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Rolta India | 312.30 | 23.68 | | Puravankara Projects | 361.15 | 13.89 | | EIH | 181.60 | 12.90 | | BPCL | 432.55 | 12.44 | | Reliance Comm | 685.00 | 11.96 | | Losers | | J&K Bank | 753.45 | -1.87 | | Punj Lloyd | 395.45 | -1.40 | | HDFC Bank | 1,548.25 | -1.21 | | GIPCL | 104.55 | -1.04 | | Apollo Hospitals | 489.35 | -0.99 | | | Market Statistics | | - | BSE | NSE | | Advances | 2,274 | 1,011 | | Declines | 533 | 179 | | Unchanged | 37 | 12 | | Volume(Nos) | 31.66cr | 50.09cr | | | | | | Market Commentary | | | Strong global cues trigger rally | | Backed by positive global reports, the Sensex closed firm at 18,660 on all-round buying support. | | All-round buying continued for the second straight session, with the Sensex gaining nearly 400 points during the intra-day trades on strong global cues. | | | | Riding on the back of firm Asian indices, the Sensex resumed 250 points higher at 18,496 and soon edged past 18,895 in the early trades. While the market remained buoyant above 18,400 levels for the most part, buying accelerated towards the close with gains in heavyweights, realty, technology, information technology (IT), and public sector unit (PSU) stocks lifting the index to an intra-day high of 18,895. The Sensex closed the session with gains of 418 points at 18,660, while the Nifty advanced 146 points at 5,463. | | | Movers & Shakers | - Satyam edged higher on report that Byrraju Foundation & Satyam has made telemedicine available to millions.
- Prithvi Information Solutions rallied sharply on getting orders worth Rs300 crore from BSNL.
- Cadila Healthcare jumped on reports that the Company has signed a research agreement for a novel drug to treat inflammatory diseases.
- Ram Informatics was up a notch after it received order from eSuvidha, the government of Uttar Pradesh.
| | | |
The breadth of the market was positive. Of the 2,844 stocks traded on the BSE, 2,274 stocks advanced, 533 stocks declined and 37 stocks ended unchanged. All the sectoral indices had a decent outing. The BSE Reality index led the pack and soared 6.53% at 10,513 followed by the BSE Teck (up 4.48% at 3,573), the BSE IT index (up 4.15% at 4,097), the BSE PSU index (up 3.36% at 8,658) and the BSE Metal index (up 3.32% at 16,538).
Among the heavyweights, Reliance Communications vaulted 11.96% at Rs685, DLF rose 8.54% at Rs883, Wipro scaled up 6.16% at Rs464, TCS jumped 5.03% at Rs976, NTPC moved up by 4.36% at Rs214.45, SBI advanced 3.93% at Rs2,271, Satyam flared up 3.85% at Rs437.25 and Ranbaxy spurted 3.75% at Rs373. However, HDFC Bank, Maruti, BHEL and Reliance Energy inched marginally lower.
Realty stocks notched up significant gains. Puravankara flared up 13.89% at Rs361.15, Sobha Developers spurted 8.46% at Rs810, Indiabulls Reality scaled up 7.61% at Rs678.60 and HDFC added 6.46% at Rs978. In the tech segment, Rolta surged 23.68% at Rs312.30, Reliance Communications jumped 11.96% at Rs685, Mphasis appreciated by 11.33% at Rs274.70 and Tata Teleservices advanced 9.67% at Rs38.55. TV18, Tech Mahindra, Wipro, Adlabs, I-Flex and TCS moved up by over 4-6% each.
Over 1.87 crore Ispat shares changed hands on the BSE followed by RNRL (1.49 crore shares), Tata Teleservices (97 lakh shares), RPL (92 lakh shares) and IFCI (85 lakh shares).
| | | | | | | | European Indices at 16:25 IST on 04-02-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6036.00 | 6.80 | 0.11 | | CAC 40 Index | 4991.43 | 13.37 | 0.27 | | DAX Index | 7025.86 | 57.19 | 0.82 | | | | | | | | | | | Asian Indices at close on 04-02-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 13859.70 | 362.54 | 2.69 | | Hang Seng Index | 25032.08 | 908.50 | 3.77 | | Kospi Index | 1690.13 | 55.60 | 3.40 | | Jakarta Composite Index | 2701.63 | 54.81 | 2.07 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
